- Home
- HOWL vs SER Comparison
HOWL vs SER Comparison
Compare HOWL & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOWL
- SER
- Stock Information
- Founded
- HOWL 2017
- SER 2017
- Country
- HOWL United States
- SER United States
- Employees
- HOWL N/A
- SER N/A
- Industry
- HOWL Biotechnology: Pharmaceutical Preparations
- SER Biotechnology: Pharmaceutical Preparations
- Sector
- HOWL Health Care
- SER Health Care
- Exchange
- HOWL Nasdaq
- SER Nasdaq
- Market Cap
- HOWL 53.8M
- SER 56.5M
- IPO Year
- HOWL 2021
- SER 2018
- Fundamental
- Price
- HOWL $1.21
- SER $5.85
- Analyst Decision
- HOWL Strong Buy
- SER Strong Buy
- Analyst Count
- HOWL 3
- SER 1
- Target Price
- HOWL $8.33
- SER $11.00
- AVG Volume (30 Days)
- HOWL 490.7K
- SER 17.8K
- Earning Date
- HOWL 08-07-2025
- SER 08-08-2025
- Dividend Yield
- HOWL N/A
- SER N/A
- EPS Growth
- HOWL N/A
- SER N/A
- EPS
- HOWL N/A
- SER N/A
- Revenue
- HOWL $1,143,000.00
- SER $51,000.00
- Revenue This Year
- HOWL N/A
- SER N/A
- Revenue Next Year
- HOWL N/A
- SER N/A
- P/E Ratio
- HOWL N/A
- SER N/A
- Revenue Growth
- HOWL N/A
- SER N/A
- 52 Week Low
- HOWL $0.60
- SER $3.81
- 52 Week High
- HOWL $4.18
- SER $12.69
- Technical
- Relative Strength Index (RSI)
- HOWL 51.44
- SER 50.74
- Support Level
- HOWL $1.19
- SER $5.78
- Resistance Level
- HOWL $1.35
- SER $6.30
- Average True Range (ATR)
- HOWL 0.13
- SER 0.35
- MACD
- HOWL -0.02
- SER -0.03
- Stochastic Oscillator
- HOWL 21.84
- SER 36.74
About HOWL Werewolf Therapeutics Inc.
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.
About SER Serina Therapeutics Inc.
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.